Skip to main content
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1987 Sep 5;295(6598):567–569. doi: 10.1136/bmj.295.6598.567

Temporal relation of antigenaemia and loss of antibodies to core antigens to development of clinical disease in HIV infection.

C Pedersen 1, C M Nielsen 1, B F Vestergaard 1, J Gerstoft 1, K Krogsgaard 1, J O Nielsen 1
PMCID: PMC1248741  PMID: 3117234

Abstract

A total of 276 sequential serum samples from 34 men with antibodies to the human immunodeficiency virus (HIV) followed up for two to seven years were analysed for HIV antigen and antibodies to the viral core and envelope proteins. Results were correlated with clinical outcome and CD4 T lymphocyte count. Both antigenaemia and the disappearance of antibodies to the core protein were associated with development of the acquired immune deficiency syndrome (AIDS) or AIDS related complex and depletion of CD4 cells. Thus AIDS or AIDS related complex developed in eight out of 16 patients with antigenaemia compared with one out of 18 patients without antigenaemia. Low counts of CD4 cells (less than 0.5 X 10(9)/l) were found in 14 of the 16 patients with antigenaemia and five of the 18 without antigenaemia. Nine patients seroconverted to HIV during the study; two of these developed antigenaemia 14 and 16 months after the estimated time of seroconversion. These results show that the late stages of HIV infection are characterised by increased production of antigen and a decrease in antibodies directed against the core protein. Antigenaemia indicates a poor prognosis; and as the antigen test is simple to do and interpret, it may therefore be useful for selecting patients for antiviral treatment.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allain J. P., Laurian Y., Paul D. A., Senn D. Serological markers in early stages of human immunodeficiency virus infection in haemophiliacs. Lancet. 1986 Nov 29;2(8518):1233–1236. doi: 10.1016/s0140-6736(86)92673-5. [DOI] [PubMed] [Google Scholar]
  2. Biggar R. J., Melbye M., Ebbesen P., Alexander S., Nielsen J. O., Sarin P., Faber V. Variation in human T lymphotropic virus III (HTLV-III) antibodies in homosexual men: decline before onset of illness related to acquired immune deficiency syndrome (AIDS). Br Med J (Clin Res Ed) 1985 Oct 12;291(6501):997–998. doi: 10.1136/bmj.291.6501.997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Gerstoft J., Malchow-Møller A., Bygbjerg I., Dickmeiss E., Enk C., Halberg P., Haahr S., Jacobsen M., Jensen K., Mejer J. Severe acquired immunodeficiency in European homosexual men. Br Med J (Clin Res Ed) 1982 Jul 3;285(6334):17–19. doi: 10.1136/bmj.285.6334.17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Goudsmit J., Lange J. M., Paul D. A., Dawson G. J. Antigenemia and antibody titers to core and envelope antigens in AIDS, AIDS-related complex, and subclinical human immunodeficiency virus infection. J Infect Dis. 1987 Mar;155(3):558–560. doi: 10.1093/infdis/155.3.558. [DOI] [PubMed] [Google Scholar]
  5. Goudsmit J., de Wolf F., Paul D. A., Epstein L. G., Lange J. M., Krone W. J., Speelman H., Wolters E. C., Van der Noordaa J., Oleske J. M. Expression of human immunodeficiency virus antigen (HIV-Ag) in serum and cerebrospinal fluid during acute and chronic infection. Lancet. 1986 Jul 26;2(8500):177–180. doi: 10.1016/s0140-6736(86)92485-2. [DOI] [PubMed] [Google Scholar]
  6. Hayward R. A., Shapiro M. F., Oye R. K. Laboratory testing on cerebrospinal fluid. A reappraisal. Lancet. 1987 Jan 3;1(8523):1–4. doi: 10.1016/s0140-6736(87)90698-2. [DOI] [PubMed] [Google Scholar]
  7. Kalyanaraman V. S., Cabradilla C. D., Getchell J. P., Narayanan R., Braff E. H., Chermann J. C., Barré-Sinoussi F., Montagnier L., Spira T. J., Kaplan J. Antibodies to the core protein of lymphadenopathy-associated virus (LAV) in patients with AIDS. Science. 1984 Jul 20;225(4659):321–323. doi: 10.1126/science.6330889. [DOI] [PubMed] [Google Scholar]
  8. Kenny C., Parkin J., Underhill G., Shah N., Burnell B., Osborne E., Jeffries D. J. HIV antigen testing. Lancet. 1987 Mar 7;1(8532):565–566. doi: 10.1016/s0140-6736(87)90210-8. [DOI] [PubMed] [Google Scholar]
  9. Lange J. M., Coutinho R. A., Krone W. J., Verdonck L. F., Danner S. A., van der Noordaa J., Goudsmit J. Distinct IgG recognition patterns during progression of subclinical and clinical infection with lymphadenopathy associated virus/human T lymphotropic virus. Br Med J (Clin Res Ed) 1986 Jan 25;292(6515):228–230. doi: 10.1136/bmj.292.6515.228. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Lange J. M., Paul D. A., Huisman H. G., de Wolf F., van den Berg H., Coutinho R. A., Danner S. A., van der Noordaa J., Goudsmit J. Persistent HIV antigenaemia and decline of HIV core antibodies associated with transition to AIDS. Br Med J (Clin Res Ed) 1986 Dec 6;293(6560):1459–1462. doi: 10.1136/bmj.293.6560.1459. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Lange J., Goudsmit J. Decline of antibody reactivity to HIV core protein secondary to increased production of HIV antigen. Lancet. 1987 Feb 21;1(8530):448–448. doi: 10.1016/s0140-6736(87)90148-6. [DOI] [PubMed] [Google Scholar]
  12. Nielsen C. M., Bygbjerg I. C., Vestergaard B. F. Detection of HIV antigens in eluates from whole blood collected on filterpaper. Lancet. 1987 Mar 7;1(8532):566–567. doi: 10.1016/s0140-6736(87)90213-3. [DOI] [PubMed] [Google Scholar]
  13. Pedersen C., Kolby P., Sindrup J. H., Arendrup M., Wulf H. C., Gaub J., Gerstoft J., Lindhardt B. O. Immunological studies in homosexual men with and without antibodies to human T-cell lymphotropic virus type III. Dan Med Bull. 1986 Oct;33(5):270–272. [PubMed] [Google Scholar]
  14. Wall R. A., Denning D. W., Amos A. HIV antigenaemia in acute HIV infection. Lancet. 1987 Mar 7;1(8532):566–566. doi: 10.1016/s0140-6736(87)90211-x. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES